Biolase (BIOL) stock price, revenue, and financials

Biolase market cap is $26.5 m, and annual revenue was $37.80 m in FY 2019

$26.5 M

BIOL Mkt cap, 24-Nov-2020

$2.9 M

Biolase Revenue Q2, 2020
Biolase Gross profit (Q2, 2020)941 K
Biolase Gross profit margin (Q2, 2020), %32%
Biolase Net income (Q2, 2020)-4.7 M
Biolase EBIT (Q2, 2020)-4 M
Biolase Cash, 30-Jun-20205.4 M
Biolase EV37.7 M

Biolase Revenue

Biolase revenue was $37.80 m in FY, 2019

Embed Graph

Biolase Income Statement

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

12.1m13.1m12.3m12.2m13.8m14.6m14.2m12.3m11.5m10.2m12.7m10.9m11.9m11.2m11.0m13.8m13.2m10.9m12.6m10.8m10.0m12.2m10.9m10.3m8.6m8.6m4.8m2.9m

Cost of goods sold

6.5m7.7m6.5m7.8m7.5m8.8m8.7m8.5m7.6m6.5m7.3m7.6m8.2m7.9m7.4m8.2m7.6m6.9m7.9m8.0m7.0m7.8m7.0m6.8m5.3m5.7m3.4m2.0m

Gross profit

5.6m5.3m5.8m4.4m6.3m5.8m5.6m3.8m3.9m3.7m5.4m3.2m3.7m3.4m3.6m5.7m5.6m4.0m4.7m2.9m3.0m4.3m3.9m3.5m3.4m3.0m1.4m941.0k

Gross profit Margin, %

46%41%47%36%46%40%39%31%34%37%42%30%31%30%33%41%42%36%37%26%30%35%36%34%39%34%28%32%

Sales and marketing expense

3.0m3.2m4.0m3.7m3.6m5.3m4.1m4.2m4.5m3.6m3.9m4.8m4.7m4.0m3.8m4.5m4.3m4.2m4.5m4.0m3.9m4.7m4.5m3.9m3.3m3.5m2.7m2.1m

R&D expense

1.1m1.1m1.2m1.3m1.2m1.0m1.0m977.0k973.0k978.0k1.3m1.8m2.0m1.8m1.9m1.9m1.7m1.4m1.8m1.6m1.3m1.4m1.3m1.4m1.1m1.1m991.0k690.0k

General and administrative expense

2.2m2.0m2.2m2.2m1.8m2.2m2.6m2.5m3.1m5.3m3.5m2.6m3.9m2.9m2.3m2.7m2.8m2.4m2.8m2.0m3.0m3.0m2.7m2.4m2.5m3.2m3.0m2.1m

Operating expense total

6.3m6.3m7.4m7.2m6.7m8.6m7.9m7.7m8.6m9.9m8.7m8.5m10.7m8.7m8.0m9.0m8.8m8.0m9.2m7.6m8.2m9.0m8.5m7.9m6.7m7.9m6.7m4.9m

EBIT

(717.0k)(938.0k)(1.6m)(1.7m)(388.0k)(2.8m)(2.3m)(3.9m)(4.6m)(6.2m)(3.3m)(5.3m)(7.0m)(5.4m)(4.3m)(3.4m)(3.1m)(4.1m)(4.5m)(4.8m)(5.2m)(4.7m)(4.5m)(4.4m)(3.3m)(4.9m)(5.4m)(4.0m)

EBIT margin, %

(6%)(7%)(13%)(14%)(3%)(19%)(16%)(31%)(40%)(61%)(26%)(48%)(59%)(48%)(39%)(25%)(24%)(37%)(36%)(44%)(52%)(38%)(41%)(42%)(39%)(56%)(112%)(135%)

Interest expense

6.0k2.0k5.0k38.0k98.0k87.0k117.0k182.0k230.0k185.0k172.0k130.0k23.0k21.0k17.0k17.0k18.0k9.0k10.0k10.0k12.0k35.0k33.0k

Interest income

1.0k

Pre tax profit

(739.0k)(896.0k)(1.6m)(1.8m)(514.0k)(3.0m)(2.4m)(4.0m)(4.9m)(6.4m)(3.5m)(5.4m)(7.0m)(5.3m)(4.2m)(3.5m)(3.1m)(4.1m)(4.3m)(4.6m)(5.0m)(4.9m)(4.6m)(4.9m)(3.9m)(5.5m)(6.0m)(4.6m)

Income tax expense

14.0k57.0k29.0k34.0k34.0k(372.0k)168.0k22.0k24.0k29.0k28.0k47.0k36.0k44.0k40.0k37.0k40.0k40.0k36.0k35.0k32.0k10.0k49.0k15.0k28.0k26.0k(19.0k)53.0k

Net Income

(753.0k)(953.0k)(1.7m)(1.9m)(548.0k)(2.6m)(2.6m)(4.0m)(4.9m)(6.4m)(3.5m)(5.4m)(7.0m)(5.3m)(4.3m)(3.5m)(3.1m)(4.1m)(4.3m)(4.6m)(5.0m)(4.9m)(4.7m)(4.9m)(3.9m)(5.5m)(6.0m)(4.7m)

Biolase Balance Sheet

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

10.1m5.8m2.8m1.6m1.3m1.2m2.1m4.2m1.8m2.1m2.8m23.7m19.9m15.2m6.6m4.9m12.7m3.6m7.9m4.5m8.5m2.9m2.2m3.0m3.7m2.1m1.5m5.4m

Accounts Receivable

6.4m8.1m9.0m9.6m10.3m10.6m11.5m10.8m8.6m6.6m9.3m9.8m9.8m9.2m10.1m11.0m9.9m9.2m9.8m9.7m9.7m10.4m11.4m11.7m9.7m8.5m4.7m4.1m

Prepaid Expenses

771.0k1.2m1.2m1.3m1.1m1.6m1.3m1.1m1.3m909.0k1.3m2.0m1.6m1.5m1.6m1.1m895.0k1.6m1.3m1.2m1.7m1.6m771.0k1.8m952.0k875.0k1.2m1.1m

Inventories

8.0m9.8m10.3m10.7m11.2m11.9m12.6m11.7m11.9m11.9m11.8m13.2m13.7m14.1m12.6m11.3m13.5m14.7m15.2m14.1m13.4m14.0m13.4m12.0m12.3m11.5m12.2m11.9m

Current Assets

25.3m24.9m23.3m23.4m23.9m25.4m27.5m27.8m23.6m21.4m25.1m49.0m45.2m40.3m31.1m28.5m37.3m29.3m34.5m29.7m33.6m29.2m28.0m28.8m27.1m23.3m20.0m22.9m

PP&E

1.2m1.2m1.3m1.3m1.5m1.6m1.6m1.7m1.7m1.6m1.5m1.7m2.4m3.1m3.8m4.0m3.9m4.5m4.6m4.4m3.4m3.2m2.9m1.7m1.6m1.3m1.0m781.0k

Goodwill

2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m2.9m

Total Assets

29.9m29.4m27.9m28.2m28.8m30.5m32.5m32.9m28.7m26.4m29.9m54.7m51.3m47.1m38.4m36.0m44.6m37.0m42.3m37.4m40.4m35.6m34.3m33.8m32.4m28.3m24.5m27.8m

Accounts Payable

5.0m5.9m7.5m6.9m7.2m8.7m9.3m9.3m7.8m10.0m9.5m7.6m8.8m9.3m7.0m6.9m7.9m9.2m8.2m7.7m5.8m6.9m7.6m5.9m5.9m6.6m4.1m2.5m

Short-term debt

1.9m2.2m3.3m6.0m5.5m2.9m3.3m1.5m13.6m13.5m

Current Liabilities

13.6m13.7m15.2m16.8m17.7m20.3m23.7m22.7m19.0m22.6m17.8m15.8m17.9m18.3m14.5m15.0m16.4m17.1m15.6m15.0m13.1m14.7m17.3m15.1m13.3m14.1m23.7m21.1m

Long-term debt

8.0m8.0m8.0m7.5m240.0k238.0k201.0k117.0k74.0k32.0k1.8m10.9m13.3m13.4m3.1m

Total Debt

9.9m10.2m11.3m13.5m5.5m2.9m3.3m240.0k238.0k201.0k117.0k74.0k32.0k1.8m1.5m10.9m13.3m13.4m13.6m16.7m

Total Liabilities

15.0m15.1m16.0m17.6m18.4m20.8m24.3m23.4m19.7m23.5m18.8m17.6m20.3m20.8m16.8m17.0m18.6m18.7m17.0m16.2m15.4m15.3m17.9m26.8m28.6m29.3m25.4m26.4m

Common Stock

32.0k33.0k33.0k33.0k33.0k34.0k34.0k37.0k40.0k40.0k44.0k58.0k58.0k58.0k58.0k58.0k68.0k68.0k76.0k76.0k102.0k20.0k20.0k21.0k22.0k22.0k32.0k50.0k

Preferred Stock

4.0m

Additional Paid-in Capital

137.7m138.1m139.5m140.1m140.4m141.3m142.4m147.7m154.3m154.6m150.1m186.0m186.9m187.5m189.5m190.4m200.6m201.6m212.6m213.0m225.5m226.1m226.7m229.3m230.0m230.7m236.4m247.2m

Retained Earnings

(106.2m)(107.2m)(110.9m)(112.8m)(113.3m)(114.9m)(117.5m)(121.5m)(128.6m)(135.1m)(138.6m)(148.1m)(155.2m)(160.5m)(167.2m)(170.8m)(173.9m)(182.4m)(186.7m)(191.3m)(200.2m)(205.1m)(209.8m)(221.6m)(225.5m)(231.0m)(240.6m)(245.3m)

Total Equity

14.9m14.3m11.9m10.6m10.3m9.7m8.2m9.5m9.0m2.9m11.1m37.1m31.1m26.3m21.6m19.0m26.1m18.4m25.3m21.2m24.9m20.4m16.3m7.0m3.8m(1.1m)(4.9m)1.3m

Financial Leverage

2 x2.1 x2.3 x2.7 x2.8 x3.2 x4 x3.5 x3.2 x9.1 x2.7 x1.5 x1.7 x1.8 x1.8 x1.9 x1.7 x2 x1.7 x1.8 x1.6 x1.7 x2.1 x4.8 x8.5 x-26.5 x-5.1 x21.2 x

Biolase Cash Flow

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(1.5m)(2.5m)(1.7m)(3.5m)(4.1m)(2.6m)(5.2m)(9.2m)(4.9m)(11.3m)(14.8m)(5.4m)(12.5m)(17.8m)(4.3m)(7.8m)(10.9m)(4.1m)(8.4m)(13.0m)(5.0m)(9.9m)(14.6m)(4.9m)(8.8m)(14.3m)(6.0m)(10.7m)

Depreciation and Amortization

411.0k562.0k125.0k247.0k373.0k145.0k298.0k439.0k193.0k352.0k529.0k158.0k324.0k589.0k212.0k488.0k776.0k290.0k577.0k887.0k264.0k509.0k712.0k258.0k529.0k754.0k177.0k488.0k

Accounts Receivable

(3.1m)(4.8m)(100.0k)(992.0k)1.1m1.0m112.0k608.0k2.3m3.8m1.1m(860.0k)(1.0m)(500.0k)(1.1m)(2.0m)(863.0k)564.0k(55.0k)52.0k186.0k(504.0k)(1.6m)(650.0k)1.3m1.4m3.0m3.6m

Inventories

(1.2m)(3.0m)975.0k612.0k(112.0k)(779.0k)(1.4m)(1.7m)(774.0k)(733.0k)(682.0k)(664.0k)(1.2m)(1.6m)(1.0k)908.0k(1.4m)(1.4m)(1.9m)(914.0k)(1.1m)(1.8m)(1.2m)225.0k(86.0k)711.0k(1.2m)(937.0k)

Accounts Payable

1.2m2.4m(957.0k)(2.2m)(1.6m)(659.0k)490.0k240.0k(392.0k)3.3m2.4m(1.1m)1.2m1.6m(155.0k)25.0k2.1m(885.0k)(2.7m)(3.2m)460.0k2.1m3.2m(1.5m)(1.7m)(1.2m)(1.5m)(3.8m)

Cash From Operating Activities

(7.1m)(11.3m)(593.0k)(3.3m)(3.5m)(2.8m)(5.1m)(7.1m)(2.8m)(2.9m)(10.3m)(7.4m)(11.0m)(15.0m)(4.8m)(6.3m)(7.5m)(5.1m)(10.9m)(14.2m)(4.8m)(8.3m)(10.6m)(5.0m)(6.6m)(8.1m)(4.1m)(9.3m)

Purchases of PP&E

(157.0k)(294.0k)(266.0k)(457.0k)(715.0k)(139.0k)(331.0k)(464.0k)(86.0k)(123.0k)(194.0k)(228.0k)(433.0k)(1.3m)(343.0k)(502.0k)(1.1m)(208.0k)(637.0k)(825.0k)(102.0k)(110.0k)(110.0k)(8.0k)(125.0k)(138.0k)(9.0k)(81.0k)

Cash From Investing Activities

(157.0k)(294.0k)(266.0k)(457.0k)(591.0k)(149.0k)(341.0k)(474.0k)(85.0k)(122.0k)(193.0k)(228.0k)(433.0k)(1.2m)(343.0k)(502.0k)(1.1m)(208.0k)(637.0k)(825.0k)(102.0k)(110.0k)(74.0k)(8.0k)(125.0k)(138.0k)(9.0k)(81.0k)

Short-term Borrowings

(415.0k)(7.3m)(6.7m)(15.2m)(23.4m)(9.3m)(16.9m)(21.5m)(1.8m)(1.8m)

Long-term Borrowings

(2.7m)(2.7m)(24.0k)(43.0k)(86.0k)(143.0k)(43.0k)(86.0k)(128.0k)(46.0k)(46.0k)(46.0k)(3.0m)

Cash From Financing Activities

15.6m15.6m277.0k2.1m2.1m1.7m5.1m9.2m3.3m3.7m11.9m2.0k2.0k(22.0k)(43.0k)(86.0k)9.4m(43.0k)10.4m10.3m1.6m(269.0k)1.2m3.0k2.5m2.4m(117.0k)9.0m

Net Change in Cash

8.4m4.1m(535.0k)(1.7m)(2.0m)(1.3m)(442.0k)1.6m395.0k643.0k1.3m(7.8m)(11.6m)(16.4m)(5.1m)(6.8m)951.0k(5.3m)(1.0m)(4.5m)(3.2m)(8.7m)(9.5m)(5.1m)(4.3m)(6.0m)(4.3m)(352.0k)

Interest Paid

79.0k81.0k3.0k10.0k45.0k31.0k81.0k165.0k67.0k101.0k143.0k2.0k1.0k2.0k3.0k1.0k1.0k1.0k430.0k831.0k1.3m485.0k466.0k

Income Taxes Paid

8.0k8.0k21.0k29.0k51.0k45.0k49.0k51.0k5.0k34.0k45.0k37.0k44.0k53.0k33.0k48.0k66.0k7.0k137.0k166.0k24.0k15.0k31.0k31.0k12.0k19.0k28.0k26.0k

Biolase Ratios

USDQ2, 2011

Financial Leverage

2 x

Biolase Employee Rating

2.449 votes
Culture & Values
2.2
Work/Life Balance
2.7
Senior Management
2.1
Salary & Benefits
2.5
Career Opportunities
2.1
Source